Randomized Phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder
Truls Gårdmark, Malcolm Carringer, Eva Beckman, Per-Uno MalmströmVolume:
66
Year:
2005
Language:
english
DOI:
10.1016/j.urology.2005.03.084
File:
PDF, 145 KB
english, 2005